Skip to content

Veracyte

US · VCYT #2330 by market cap Listed 1970
25.13 +0.09 +0.36%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Veracyte

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Founded
2006
CEO
Mr. Marc A. Stapley
Employees
755
Headquarters
South San Francisco, California, United States of America
Fiscal year end
12-31
Website
veracyte.com

Company profile

Exchange
US
Symbol
VCYT
Market-cap rank
#2330
Listing date
1970-01-01
Market cap
2.03B
Float cap
2.02B
Shares out
80.70M
Float shares
80.19M

Sectors & themes

Diagnostics & Research ARK Portfolio Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Veracyte discussion 0 comments

Add a comment